Bioequivalence and Safety of Twice‐Daily Sustained‐Release Paracetamol (Acetaminophen) Compared With 3‐ and 4‐Times‐Daily Paracetamol: A Repeat‐Dose, Crossover Pharmacokinetic Study in Healthy Volunteers

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|1|77-86

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.1, 2018-01, pp. : 77-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection of 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained‐Release Prototype Formulations and Standard Acetaminophen Formulation: An Open‐Label, Randomized, Proof‐of‐Principle Pharmacokinetic Study

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 87-94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient Preference for Sustained-release versus Standard Paracetamol (Acetaminophen): a Multicentre, Randomized, Open-label, Two-way Crossover Study in Subjects with Knee Osteoarthritis

By Benson M   Marangou A   Russo MA   Durocher J   Collaku A   Starkey YY  

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1321-1335

Field House Publishing

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite